Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Preferred Stock Liabilities (2017 - 2018)

Updated

Crinetics Pharmaceuticals' Preferred Stock Liabilities came in at $92.98 million for Q2 2018.

Analysis

Crinetics Pharmaceuticals (CRNX) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

At the end of FY2017, Crinetics Pharmaceuticals' Preferred Stock Liabilities was $29.7 million, up 67.4% from FY2016.

  • Going back by year, Preferred Stock Liabilities was $17.74 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 92.98 Mn
Dec 31, 2017 29.70 Mn
API Access

Crinetics Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CRNX&period=max&api_key=YOUR_API_KEY